Results 161 to 170 of about 282,905 (301)

Exploring the ecological drivers of bacteriophage diversity and functional viral potential in the skin of the axolotl Ambystoma altamirani. [PDF]

FEMS Microbiol Ecol
Cisneros-Martínez AM, Flores Varela MÁ, González-Serrano F, Rebollar EA.   +3 more
europepmc   +1 more source

Integrating One Health to Mitigate the Emergence and Spread of Antimicrobial Resistance in Livestock and Aquaculture

Animal Research and One Health, EarlyView.
Antimicrobial resistance (AMR) is an escalating global threat driven by antimicrobial use in aquaculture and livestock. Resistant pathogens and genes can spread across humans, animals, and the environment through interconnected ecosystems. Using a One Health approach, this review emphasizes antimicrobial stewardship, regulatory strengthening, enhanced ...
Mir Mohammad Ali, Delower Hossain, Ridwan Olamilekan Adesola, Anum Hanif, Shamsaldeen Ibrahim Saeed, Muhammad Abdul Mannan, Anoar Jamai Masroure, Kazi Estieque Alam, Md Kamal Hossain, Sabiha Zarin Tasnim Bristi, Md Jisan Ahmed   +10 more
wiley   +1 more source

Environmental isolation and in vitro characterisation of bacteriophages active against multidrug-resistant <i>Acinetobacter baumannii</i>. [PDF]

Infez Med
Chowdhury S, Rathor N, Soneja M, Das BK, Jadon RS, Wig N, Chaudhry R.   +6 more
europepmc   +1 more source

S. aureus colonization and clinical symptoms remain stable upon topical XZ.700 treatment: Results of a double‐blind randomized clinical trial in patients with mild to moderate atopic dermatitis

British Journal of Clinical Pharmacology, EarlyView.
Aim Recovering dysbiosis may improve atopic dermatitis (AD) symptoms. XZ.700 is a recombinant chimeric endolysin that specifically targets Staphylococcus aureus and could be a new treatment option for patients with AD. The aim of this first‐in‐human study was to evaluate the safety, tolerability and efficacy of topical XZ.700 and explore the ...
Laura W. J. van der Meulen, Menthe E. Bergmans, Salma Assil, Naomi Klarenbeek, Marieke L. de Kam, Alexa J. Tibboel, Thorsten Brach, Bjorn L. Herpers, Johan Frieling, Vincent de Jong, Benthe Freyee, Martijn B. A. van Doorn, Robert Rissmann, Tessa Niemeyer–van der Kolk   +13 more
wiley   +1 more source

Bacteriophage Challenge Drives Genomic and Proteomic Remodeling and Alters Antibiotic Resistance in a Methicillin-Resistant <i>Staphylococcus aureus</i>. [PDF]

Antibiotics (Basel)
Vágó O, Laczi K, Orosz L, Horváth G, Sárvári KP, Szabó D, Csordás R, Szabó Z, Ardizzone C, Szögi T, Burián K, Virok DP.   +11 more
europepmc   +1 more source

Biochemical Studies on Bacteriophage PBS 1

, 1968
No abstract provided.ThesisDoctor of Philosophy ...
Tomita, Fusao
core  

Scalable Separation and Purification of M13‐Bacteriophage‐Derived Particles Containing Artificial Single‐Stranded DNA Produced by Escherichia coli

Biotechnology and Bioengineering, EarlyView.
ABSTRACT Single‐stranded DNA (ssDNA) solutions are promising innovations shaping the future of genetic research and medical therapies. In principle, biotechnological mass production of ssDNA can be achieved using Escherichia coli in a high‐cell density fed‐batch process by secreting phagemid particles derived from the filamentous M13 bacteriophages ...
Nathalie Hafner, Wiebke Winkler, Maximilian N. Honemann, Hendrik Dietz, Dirk Weuster‐Botz   +4 more
wiley   +1 more source

Phage anti-defense genes targeting NAD⁺ metabolism and DNA replication are associated with a broad host range against <i>Klebsiella pneumoniae</i>. [PDF]

Virulence
Lei B, Xu Y, Zhu K, Gao K, Li Y, Li X, Xu X, Li H, Hu R, Wang Y, Dai J, Li Z, Lv Y, Ge W, Ni W, Hu S.   +15 more
europepmc   +1 more source

Things Are Getting Hairy: Enterobacteria Bacteriophage vB_PcaM_CBB [PDF]

, 2017
Neve, Horst, Buttimer, C., Hendrix, H., Casey, A., McAuliffe, O., Hill, C., Noben, J.-P., Oliveira, H., Ross, P.R., O'Mahony, J., Lavigne, R., Coffey, A.   +11 more
core  

Purification of Disassembled Capsid Protein by Hydroxyapatite Chromatography Enhances Virus‐Like Particle Recovery

Biotechnology and Bioengineering, EarlyView.
ABSTRACT Virus‐like particles (VLPs) are a promising modality with extensive applications in prophylactic and therapeutic vaccine design. Human Papillomavirus (HPV) vaccines are one such example where VLP vaccine applications have led to the successful reduction in HPV‐associated diseases, such as cervical cancer.
Nicholas Samuelson, Nathaniel Parker, Shiyi Wang, Sara Daley, Aaron Cote, Michael A. Winters   +5 more
wiley   +1 more source